Persistent organic pollutants (POPs) threaten human, animal, and ecosystem health, creating an urgent need for predictive, mechanism-based approaches to chemical risk assessment. In response, international bodies such as the OECD and WHO increasingly recognize omics technologies as pivotal tools for next-generation hazard evaluation. Evidence synthesized across studies on both legacy and emerging POPs reveals a notable convergence of molecular responses, with omics analyses consistently identifying a limited set of modes of action. These converging responses encompass five broad mechanistic domains: (i) disruption of lipid, amino acid, and energy metabolism through nuclear receptor-mediated pathways; (ii) activation of inflammatory and immune signaling cascades; (iii) induction of oxidative stress; (iv) perturbation of neuronal function and synaptic signaling; and (v) impairment of cell growth, survival, genomic integrity, and xenobiotic detoxification. The recurrence of these molecular signatures across different classes of POPs, including replacement compounds, highlights the possible value of omics data for comparative hazard assessment, thereby supporting authorities’ efforts to prevent regrettable chemical substitution. However, the current evidence base is largely exploratory: most studies employ short-term exposures, focus on hepatic or neural tissues, assess limited endpoints, and lack environmental relevance. Limited multi-omics integration, inconsistent analytical transparency, and weak connections to adverse outcome pathways (AOPs) further constrain regulatory application. Advancing harmonized experimental designs, standardized workflows, explicit AOP mapping, and integrated multi-omics approaches is essential for enabling next-generation POP risk assessment within a One Health framework, an approach that treats human, animal, and environmental health as interconnected.